![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, July 20, 2021 10:55:24 AM
So if its ok with you I will just give you the summarized version of what I have read and learned over that period of time.
First, your question is can a biotech company from an SEC point of view just sit on positive results, isn't it material, should they not disclose this as soon as they learn about it. The answer is NO a biotech in that position is not required to do so immediately. One could argue that the information is something the average investor would very much like to be disclosed as soon as the company learns about it and something that would move the stock price, but no.
The biotech company is allowed to first build the case, the underlying evidence of data why the topline is positive before releasing the summarized version of the data we call topline.
In other words, NWBO is allowed to first have the publication-ready before releasing topline data.
If you are interested a good resource Iis:
https://scholarship.law.edu/cgi/viewcontent.cgi?article=1016&context=jchlp
Predictable Materiality: A Need for Common Criteria Governing
the Disclosure of Clinical T e of Clinical Trial Results b rial Results by Publicity-T y Publicity-Traded
Pharmaceutical Companies
Then vice versa, as soon as the company learns that the data is in such way that it will most likely NOT trigger FDA drug approval in a phase 3 drug trial, in other words, the P3 trial outcome is negative. Then this information is material and should be disclosed within 4 days. In this case, the biotech company can not linger until it has built the underlying data case with for example an article in a journal.
On the Anavex board someone asked me but what if they never release positive topline data? I answered that such has never happened before and the FDA has a rule where it's stipulated that after one year of primary completion date the results should be submitted... we have talked about that extensively here as well..
Now I will probably get all kinds of remarks on this post. But since I have spent days and hours on the subject both here and on the Anavex board Im not going into further discussion. I hope my post has helped you to get an answer.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM